{"name": "OxThera",
 "permalink": "oxthera",
 "crunchbase_url": "http://www.crunchbase.com/company/oxthera",
 "homepage_url": "http://www.oxthera.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@oxthera.com",
 "phone_number": "46-018-24-4045",
 "description": "",
 "created_at": "Fri Mar 12 13:17:07 UTC 2010",
 "updated_at": "Fri Jul 02 12:06:54 UTC 2010",
 "overview": "\u003Cp\u003EOxThera is a clinical stage biotechnology company with its first product in phase III. The company is based in Sweden (Uppsala) and Florida (Gainesville). The company develops products, based on its cell- and enzyme based proprietary technologies, for metabolic disorders based on excess oxalate from endogenous and exogenous sources. OxThera will market and sell its orphan drug products to treat and prevent hyperoxaluria and kidney stones in indications such as Primary and Enteric Hyperoxaluria.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[127,
       45],
      "assets/images/resized/0008/0099/80099v1-max-150x150.jpg"],
     [[127,
       45],
      "assets/images/resized/0008/0099/80099v1-max-250x250.jpg"],
     [[127,
       45],
      "assets/images/resized/0008/0099/80099v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "kr315M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.oxthera.com/pr.php?no=2",
    "source_description": "OxThera Raises SEK 150 Million in New Round of Financing",
    "raised_amount": 150000000.0,
    "raised_currency_code": "SEK",
    "funded_year": 2007,
    "funded_month": 6,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Q-Med",
         "permalink": "q-med",
         "image":
          {"available_sizes":
            [[[139,
               45],
              "assets/images/resized/0008/0105/80105v1-max-150x150.jpg"],
             [[139,
               45],
              "assets/images/resized/0008/0105/80105v1-max-250x250.jpg"],
             [[139,
               45],
              "assets/images/resized/0008/0105/80105v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Industrifonden",
         "permalink": "industrifonden",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0003/2833/32833v1-max-150x150.png"],
             [[241,
               44],
              "assets/images/resized/0003/2833/32833v1-max-250x250.png"],
             [[241,
               44],
              "assets/images/resized/0003/2833/32833v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SLS Venture",
         "permalink": "sls-venture",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0007/1578/71578v1-max-150x150.png"],
             [[250,
               47],
              "assets/images/resized/0007/1578/71578v1-max-250x250.png"],
             [[250,
               47],
              "assets/images/resized/0007/1578/71578v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Q-Med",
         "permalink": "q-med",
         "image":
          {"available_sizes":
            [[[139,
               45],
              "assets/images/resized/0008/0105/80105v1-max-150x150.jpg"],
             [[139,
               45],
              "assets/images/resized/0008/0105/80105v1-max-250x250.jpg"],
             [[139,
               45],
              "assets/images/resized/0008/0105/80105v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.oxthera.com/pr.php?no=3",
    "source_description": "External financing of SEK 165 million secured for Q-Med's oxalate project",
    "raised_amount": 165000000.0,
    "raised_currency_code": "SEK",
    "funded_year": 2005,
    "funded_month": 7,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SLS Venture",
         "permalink": "sls-venture",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0007/1578/71578v1-max-150x150.png"],
             [[250,
               47],
              "assets/images/resized/0007/1578/71578v1-max-250x250.png"],
             [[250,
               47],
              "assets/images/resized/0007/1578/71578v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Dragarbrunnsgatan 45",
    "address2": "",
    "zip_code": "753 20",
    "city": "Uppsala",
    "state_code": null,
    "country_code": "SWE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        85],
       "assets/images/resized/0008/0100/80100v1-max-150x150.jpg"],
      [[250,
        142],
       "assets/images/resized/0008/0100/80100v1-max-250x250.jpg"],
      [[450,
        256],
       "assets/images/resized/0008/0100/80100v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}